发明名称 QUINAZOLINE COMPOUND
摘要 <P>PROBLEM TO BE SOLVED: To provide a compound or a salt thereof effective for the treatment of disease states involving angiogenesis and/or increased vascular permeability, which is an effective ingredient of medicines used for providing an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals such as human beings. Ž<P>SOLUTION: The compound comprises 7-benzyloxy-4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxyquinazoline or a salt thereof, and 4-(4-fluoro-2-methylindol-5-yloxy)-7-hydroxy-6-methoxyquinazoline or a salt thereof. The administration of the compound or a pharmaceutically acceptable salt thereof can treat disease states involving angiogenesis. The compound inhibits the action of the vascular endothelial cell growth factor (VEGF), which is a characteristic useful for the treatment of several disease states including cancer and rheumatoid arthritis. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2010100642(A) 申请公布日期 2010.05.06
申请号 JP20090297126 申请日期 2009.12.28
申请人 ASTRAZENECA AB 发明人 HENNEQUIN LAURENT FRANCOIS A
分类号 C07D403/12;C07D491/113;A61K31/517;A61K31/519;A61P3/10;A61P7/02;A61P9/00;A61P9/08;A61P9/10;A61P9/14;A61P13/12;A61P15/00;A61P17/02;A61P17/06;A61P19/02;A61P27/02;A61P29/00;A61P35/00;A61P35/02;A61P37/06;A61P43/00;C07D401/14;C07D403/14;C07D471/04;C07D491/04;C07D519/00 主分类号 C07D403/12
代理机构 代理人
主权项
地址